Overview of Medical Marijuana Legalization in Alabama by Year

Overview of Alabama Cannabis Laws by Year

A chronological breakdown of the legalization of Alabama Cannabis Laws:

2014 – Carly’s Law:

Alabama introduced Carly’s Law, allowing for the University of Alabama at Birmingham to conduct a study on cannabidiol (CBD) oil for seizure disorders. 

2016 – Leni’s Law:

Following Carly’s Law, Leni’s Law expanded the use of CBD oil to include individuals with other medical conditions beyond seizure disorders. It provided an affirmative defense for possessing CBD oil for debilitating conditions.

2019 – Compassion Act Consideration Begins:

The Alabama Senate considered the Alabama Compassion Act, but it didn’t pass.

2020 – Introduction of Medical Marijuana Legislation:

Lawmakers in Alabama introduced various bills aiming to legalize medical marijuana. These bills proposed creating a regulated system for medical cannabis use, but none of them were enacted into law.

2021 – The Darren Wesley ‘Ato’ Hall Compassion Act:

Governor Kay Ivey signed the Compassion Act into law. This legalized medical marijuana for qualified patients. As well as marked a significant milestone as Alabama became the 37th state to legalize medical marijuana. This comprehensive legislation established the Alabama Medical Cannabis Commission to regulate the medical marijuana program. Allowing for controlled access to medical cannabis for specific debilitating conditions.

This law set the groundwork for a tightly regulated medical marijuana program. As well as defining qualifying conditions, creating a patient registry, establishing guidelines for cultivation, distribution, and ensuring legal access through the issuance of medical marijuana cards.

Each step, from Carly’s Law to the eventual passing of the Compassion Act. Marking progress in Alabama’s approach to medical marijuana. Leading to the establishment of a legal framework for its use in a medical context.

This progression demonstrates the state’s evolving stance on medical cannabis. From initial research studies to the implementation of a comprehensive program aimed at providing relief to patients while adhering to strict regulatory measures.